Aside from the implications mentioned above in tumor treatment and prognosis, CD47 has been implicated to aid the diagnosis of non-small cell lung cancer [34], renal cell tumors, and hematological tumors [33]. This evidence concerns the gene CD47 and hematopoietic and lymphoid system neoplasm.